ENSG - The Ensign Group, Inc.
NEXT EARNINGS:
Apr 23, 2026
EPS Est: $1.82
|
Rev Est: $1.4B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$222.33
DETAILS
HIGH:
$230.00
LOW:
$215.00
MEDIAN:
$222.00
CONSENSUS:
$222.33
UPSIDE:
4.68%
Market Cap:
12.34B
Volume:
406,255
Avg Volume:
383,758
52 Week Range:
118.73-216.92
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
0.87
Last Dividend:
$0.25
Exchange:
NASDAQ
Country:
US
Employees:
39,300
IPO Date:
2007-11-09
EPS (TTM):
6.00
P/E Ratio:
29.02
Revenue (TTM):
5.06B
Total Assets:
5.46B
Total Debt:
4.15B
Cash & Equiv:
503.88M
Rev Growth (5Y):
16.1%
EPS Growth (5Y):
13.5%
FCF Growth (5Y):
2.8%
ROCE:
10.1%
Debt/Equity:
1.86
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $1.82 | $1.75 | +4.0% | $1.4B | $1.4B | -0.6% |
| 2025-11-03 | $1.64 | $1.59 | +3.1% | $1.3B | $1.4B | -5.2% |
| 2025-07-24 | $1.59 | $1.55 | +2.6% | $1.2B | $1.2B | +0.7% |
| 2025-04-29 | $1.52 | $1.49 | +2.0% | $1.2B | $1.2B | 0.0% |
| 2025-02-05 | $1.49 | $1.47 | +1.4% | $1.1B | $1.1B | +0.3% |
| 2024-10-24 | $1.39 | $1.38 | +0.7% | $1.1B | $1.1B | +1.1% |
| 2024-07-25 | $1.32 | $1.30 | +1.5% | $1.0B | $1.0B | +1.5% |
| 2024-05-01 | $1.30 | $1.29 | +0.8% | $982.9M | $1.0B | -2.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.06B | 4.26B | 3.73B | 3.03B | 2.63B | 2.40B | 2.04B | 1.75B | 1.60B | 1.65B | 1.34B | 1.03B |
| Net Income | 343.97M | 297.97M | 209.40M | 224.68M | 194.65M | 170.48M | 110.53M | 92.36M | 40.48M | 49.99M | 55.43M | 35.95M |
| EPS | 6.00 | 5.26 | 3.76 | 4.09 | 3.57 | 3.19 | 2.07 | 1.78 | 0.79 | 0.99 | 1.10 | 0.80 |
| Total Assets | 5.46B | 4.67B | 4.18B | 3.45B | 2.85B | 2.55B | 2.36B | 1.18B | 1.10B | 1.00B | 747.76M | 493.92M |
| Total Debt | 4.15B | 1.97B | 1.87B | 1.57B | 1.27B | 1.11B | 1.35B | 243.24M | 312.93M | 283.62M | 99.67M | 68.39M |
| Cash & Equivalents | 503.88M | 464.60M | 509.63M | 316.27M | 262.20M | 236.56M | 59.17M | 31.08M | 42.34M | 57.71M | 41.57M | 50.41M |
| Operating Cash Flow | 564.27M | 347.19M | 376.67M | 272.51M | 275.68M | 373.35M | 192.22M | 210.30M | 72.95M | 73.89M | 33.37M | 84.88M |
| Free Cash Flow | 370.71M | 188.95M | 270.49M | 184.97M | 206.13M | 323.02M | 120.68M | 155.35M | 15.79M | 8.19M | (26.65M) | 31.19M |
| FCF per Share | 6.47 | 3.34 | 4.86 | 3.37 | 3.78 | 6.05 | 2.26 | 2.99 | 0.31 | 0.16 | -0.53 | 0.70 |
| Book Value | 2.23B | 1.84B | 1.49B | 1.25B | 1.02B | 818.08M | 654.20M | 590.93M | 492.40M | 456.45M | 427.32M | 258.85M |
| Cash & ST Investments | 572.39M | 526.85M | 526.86M | 331.71M | 275.96M | 250.01M | 76.93M | 39.77M | 55.43M | 69.26M | 43.57M | 56.47M |
| ROC Equity | 0.15 | 0.16 | 0.14 | 0.18 | 0.19 | 0.21 | 0.17 | 0.16 | 0.08 | 0.11 | 0.13 | 0.14 |